National Health Investors NHI Proceeds from sales of OREO
Proceeds from sales of OREO at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans.
The official record: National Health Investors’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about National Health Investors's proceeds from sales of oreo.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is National Health Investors's proceeds from sales of OREO?
- National Health Investors (NHI) reported proceeds from sales of OREO of $6.66M in Q1 2026.
- What is the long-term trend for National Health Investors's proceeds from sales of OREO?
- Over 4 years (2021 to 2025), National Health Investors's proceeds from sales of OREO has grown at a -100.0% compound annual growth rate (CAGR), from $442.01M to $0.
- What does proceeds from sales of OREO mean?
- Represents the cash inflows received from the divestiture of real estate assets owned outright by the company. This metric highlights the company's ability to recycle capital by selling mature or non-core assets to fund new acquisitions or debt reduction. It serves as a key indicator of portfolio optimization and liquidity management.